Citi analyst Yigal Nochomovitz lowered the firm’s price target on Zai Lab to $66 from $123 and keeps a Buy rating on the shares. The analyst believes in the stock, the story, and management’s commitment to corporate profitability by the end of 2025. However, “we need to be more realistic about the magnitude of upside,” the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ZLAB:
- Zai Lab Ltd’s New Share Price & Shareholder Rights Risk – A Cause for Worry?
- Zai Lab reports FY23 EPS (35c), consensus ($3.15)
- Zai Lab Ltd (ZLAB) Q4 Earnings Cheat Sheet
- Zai Lab price target lowered to $31 from $37 at BofA
- Zai Lab weakness presents buying opportunity, says Cantor Fitzgerald
Questions or Comments about the article? Write to editor@tipranks.com